|
|
|
|
|
Customers request:
Make reactions from patents accessible
|
Symyx (MDL)’s answer:
1.5 Million Reactions (1976 onwards)
|
|
Customers request:
Include structures and data from patents, including prophetic compounds, to:
|
Symyx (MDL)’s answer: 1.6 million compounds
|
|
MDL Patent Chemistry Database
is the first database
for end-users to index
|
|
|
•1.6
million compounds
with data since 1976.
•Strong
growth anticipated:
~800,000 Compounds/Year
Your Benefit: Compounds rarely covered elsewhere,
•800,000
Prophetic Compounds since 1976.
|
|
|
Your
Benefit: Better Bioactivity
Profiling
•Measured numerical
bioactivity data (e.g. IC50, EC50) ,•Toxicology
& metabolism data, application &
formulation.
|
|
|
Approx. 1.5 M reactions
(structure-searchable;
1976 onwards),
Strong growth anticipated:
~ 500,000 reactions/year
Your Benefit:
More Effective Synthesis Planning
|
|
| For the patent authorney: | All this together enables you to understand the scope of the patent much more readily than reading the patent. |
The MDL Patent Chemistry Database can be accessed via DiscoveryGate and Commander!
Some Users of the MDL Patent Chemistry Database:
|
European Patent Office licenses MDL® Patent Chemistry Database Structure-searchable chemistry and life sciences database will improve evaluation of patent applications San Ramon, CA—November 28, 2006—Symyx (MDL) has announced that the European Patent Office (EPO) has licensed the MDL® Patent Chemistry Database for use in evaluating patent applications. The structure-searchable database, which indexes chemical reactions, substances and substance-related factual data from selected organic chemistry and life sciences patent publications, will aid the EPO in evaluating patent applications. “The MDL Patent Chemistry Database was specially designed for scientists and includes extensive measured numerical bioactivity data and many compounds that aren’t covered elsewhere,” said Dr. Trevor Heritage, Senior Vice President of Symyx (MDL). “These qualities and the ability to find data using combinations of text, structure and reaction searches will aid the EPO in efficiently assessing substances claimed in organic chemistry and life science patents. The adoption by the EPO reflects the growing importance of the database in the scientific community.” The Patent Chemistry Database covers World and European patents since 1978 and US patents since 1976. It includes more than 1 million prophetic compounds (1976- ) which are legally relevant yet not indexed in other databases; the database also covers claims text and Markush structure and reaction displays (2003- ). The database is essential to R&D scientists for planning chemical synthesis and profiling biological activities. The EPO can use the database to find chemical compounds and processes mentioned in patents (not only the claimed reactions in process patents, but also those mentioned in substance or application patents) and search for information using reactions, the chemical structures of final products and reagents, and reaction conditions (e.g., pressure, temperature, etc.). For all indexed reactions, the reaction procedure texts are provided, making it easier to check for relevance. The EPO will be able find biological activities of substances (e.g., pharmacological, agrochemical and cosmetical activity) and substance applications by searching for words in the application or biological activity data fields as well as in the patent front-page and claims text.
About European Patent Office
About Symyx (MDL)
CONTACTS: Jean Holt Senior Director Marketing & Communications Symyx (MDL) Phone: (925) 543-5400
|
|
|
|